Psoriasis located on the scalp, face, skin folds, palms/soles and nails may require special consideration due to physical disability and discomfort, and because the treatment efficacy and safety may be different. There are many therapeutic approaches for psoriasis in difficult to treat locations. Only a few of the therapies have been evaluated for efficacy and safety in well-designed and well-con-trolled clinical studies. Furthermore, comparative studies are often lacking. This chapter describes management of psoriasis located on the scalp, face, skin folds, palm/soles and nails, with special focus on treatment with topical agents.
Prof. Knud Kragballe, MD, Department of Dermatology, Århus University Hospital, Århus Sygehus, P.P.Ørums Gade 11, DK–8000 Århus C (Denmark), Tel. +45 8949 1856, Fax +45 8949 1850, E-Mail firstname.lastname@example.org
Published online: July 28, 2009
Number of Print Pages : 12
Book Serie: Current Problems in Dermatology, Vol. 38, Year 2009
Editor(s): Itin, P. (Basel)
ISSN: 1421-5721 (Print), eISSN: 1662-2944 (Online)
For additional information:
Book Title: Management of Psoriasis
Editor(s): Yawalkar N (ed)
For additional information:
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.